Cambridge Innovation Capital (Jersey) Ltd 4
4 · BICYCLE THERAPEUTICS plc · Filed May 31, 2019
Insider Transaction Report
Form 4
Transactions
- Conversion
Ordinary Shares
2019-05-28+1,081,823→ 1,081,823 total - Exercise of In-Money
Ordinary Shares
2019-05-28+125,587→ 1,207,410 total - Conversion
Ordinary Shares
2019-05-28+229,741→ 1,437,151 total - Purchase
Ordinary Shares
2019-05-29$14.00/sh+314,286$4,400,004→ 1,751,437 total - Conversion
Series B1 Preferred Shares
2019-05-28−1,081,823→ 0 total→ Ordinary Shares (1,081,823 underlying) - Exercise of In-Money
Series B1 Preferred Shares Warrants
2019-05-28−125,587→ 0 total→ Ordinary Shares (125,587 underlying) - Conversion
Series B2 Preferred Shares
2019-05-28−229,741→ 0 total→ Ordinary Shares (229,741 underlying)
Footnotes (2)
- [F1]Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date.
- [F2]Upon conversion of all of the Series B1 Preferred Shares into Ordinary Shares in connection with the Issuer's initial public offering, the Warrants became exercisable for Ordinary Shares. The Warrants had an exercise price of a nominal value per share and were exercised immediately prior to completion of the Issuer's initial public offering.